Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Supply, Demand and Key Producers, 2023-2029

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Supply, Demand and Key Producers, 2023-2029

The global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The PETIA technology has the advantages of high sensitivity, easy operation, and high degree of automation. It can be used to measure proteins, hormones, tumor markers in serum, which is of great significance.

The latex particle-enhanced immunoturbidimetric immunoassay (PETIA) is a particle-enhanced turbidimetric immunoassay technology that utilizes the particle enhancement effect and combines immunological principles to quantitatively determine the concentration of specific proteins in body fluids. In PETIA, the substance to be detected binds to a specific antibody to form an immune complex, and then latex particles (usually polystyrene particles) with affinity are added, which bind to the immune complex and form clumps. When immune complexes bind to latex particles, a turbid solution results. Next, an optical instrument is used to measure the turbidity of the solution, which is proportional to the concentration of the substance to be measured.

This report studies the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) total market, 2018-2029, (USD Million)

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) total market, key domestic companies and share, (USD Million)

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) revenue by player and market share 2018-2023, (USD Million)

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) total market by Type, CAGR, 2018-2029, (USD Million)

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gentian Diagnostics, Thermo Fisher Scientific, Buehlmann, Biotec, Abbott Laboratories, Roche, Siemens, Danaher Corporation and Diasorin SPA, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market, Segmentation by Type
Scattering Nephelometric Detection Method
Transmittance Nephelometric Detection Method

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market, Segmentation by Application
Reagent
Instrument
Others

Companies Profiled:
Gentian Diagnostics
Thermo Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Cnpair Biotech
Diagvita
Enriching Biotechnology

Key Questions Answered

1. How big is the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market?

2. What is the demand of the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market?

3. What is the year over year growth of the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market?

4. What is the total value of the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market?

5. Who are the major players in the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market?